AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Immatics N.V. Ordinary Shares
XNAS · usd
SIC 8731 · SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
FIGI BBG00VTL2J09
7.31▼ 0.23 (-3.05%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
7.54
Day's Range
7.25 – 7.50
52-Week Range
6.65 – 12.41
Volume
696.0K
Avg Volume
937.3K
Share Statistics
Shares Outstanding
Employees
407
Exchange
XNAS
Listed
2020-07-02
Share count as of December 31, 2025

Immatics N.V. Ordinary Shares (IMTX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Immatics N.V. Ordinary Shares (IMTX)
What is Immatics N.V. Ordinary Shares's Market Cap?
Immatics N.V. Ordinary Shares's Market Cap is $980.1M, based on as-reported figures from SEC (XBRL) filings.
What is Immatics N.V. Ordinary Shares's Enterprise Value?
Immatics N.V. Ordinary Shares's Enterprise Value is $714.7M, based on as-reported figures from SEC (XBRL) filings.
What is Immatics N.V. Ordinary Shares's Net Income (TTM)?
Immatics N.V. Ordinary Shares's Net Income (TTM) is -$238.2M, based on as-reported figures from SEC (XBRL) filings.
What is Immatics N.V. Ordinary Shares's Diluted EPS (TTM)?
Immatics N.V. Ordinary Shares's Diluted EPS (TTM) is -1.78, based on as-reported figures from SEC (XBRL) filings.
What is Immatics N.V. Ordinary Shares's Net Debt?
Immatics N.V. Ordinary Shares's Net Debt is -$265.4M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IMTXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of EUR, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025
Profit or loss [abstract]
Revenue from collaboration agreements
Research and development expenses
General and administrative expenses
Other income—
Operating result
Other financial income
Other financial expenses
Financial result
Loss before taxes
Net profit/(loss)
Net loss per share:
Basic
Diluted